Carmelo Rizzari

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Childhood Cancer

Intellectual Disability

Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Current oncology (Toronto, Ont.)

Pediatric blood & cancer

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Michela Bardini, Grazia Fazio, Lilia Corral Abascal, Claus Meyer, Oscar Maglia, Simona Sala, Sonia Palamini, Stefano Rebellato, Rolf Marschalek, Carmelo Rizzari, Andrea Biondi, Giovanni Cazzaniga
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia. British journal of haematology (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Patricia Blanc, Catherine Alix-Panabières, Sara Badreh, Paul Hofman, Eric Solary, Ruggero De Maria
Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis. Healthcare (Basel, Switzerland) 12 (2) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Stefan Bielack, Christopher P Fox, Khê Hoang-Xuan, Ariadna Giró-Perafita, Carmelo Rizzari
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK. Health science reports 7 (1) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Patricia Blanc, Catherine Alix-Panabières, Sara Badreh, Paul Hofman, Eric Solary, Ruggero De Maria
Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis. Healthcare (Basel, Switzerland) 12 (2) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Nicolás Tentoni, Miriam Hwang, Gabriela Villanueva, Ryan Combs, Jennifer Lowe, Laura B Ramsey, Zachary L Taylor, Thais Murciano Carrillo, María Dolores Aumente, Teresa López-Viñau López, Carmelo Rizzari, Scott C Howard
Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study. Cancer medicine 13 (17) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Stefan Bielack, Christopher P Fox, Khê Hoang-Xuan, Ariadna Giró-Perafita, Carmelo Rizzari
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK. Health science reports 7 (1) (2024)
Katherine A Janeway, Luis Gros, Stefan Schwartz, Claire Daugherty, Eva Gallardo, Christon Hill, Emma Thomas, Suzanne Ward, Carmelo Rizzari
Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials. Pediatric blood & cancer (2023)
Nobuko Hijiya, Alexey A Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco J Bautista Sirvent, Stéphane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frédéric Millot, Briana Patterson, Jill H Samis, Miguel Izquierdo, Ksenia Titorenko, Sai Li, Darintr Sosothikul
The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study. Blood advances (2023)
Katherine A Janeway, Luis Gros, Stefan Schwartz, Claire Daugherty, Eva Gallardo, Christon Hill, Emma Thomas, Suzanne Ward, Carmelo Rizzari
A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials. Pediatric blood & cancer (2023)
Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang, Harm D R van Tinteren, Vincent H J van der Velden, H Berna Beverloo, Monique L Den Boer, Lukas A J Rammeloo, Chad Hudson, Nyla Heerema, Karey Kowalski, Huadong Zhao, Luke Kuttschreuter, Francisco J Bautista Sirvent, Andrew Bukowinski, Carmelo Rizzari, Jessica A Pollard, Laura Murillo, Matthew Kutny, Sara Zarnegar, Michele S Redell, Stacy Cooper, Yves Bertrand, Arnaud Petit, Julie I Krystal, Markus Metzler, Donna Lancaster, Jean-Pierre Bourquin, Jayashree Motwani, Inge M Van der Sluis, Franco Locatelli, Michael E Roth, Nobuko Hijiya, Christian Michel Zwaan
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario, Martin Zimmermann, Andishe Attarbaschi, Jan Stary, Felix K Niggli, Luciano Dalla Pozza, Sarah Elitzur, Daniela Silvestri, Franco Locatelli, Anja Möricke, Gernot Engstler, Petr Smisek, Nicole Bodmer, Draga Barbaric, Shai Izraeli, Carmelo Rizzari, Joachim Boos, Barbara Buldini, Massimo Zucchetti, Arend von Stackelberg, Cristina Matteo, Thomas Lehrnbecher, Claudia Lanvers-Kaminsky, Giovanni Cazzaniga, Bernd Gruhn, Andrea Biondi, Martin Schrappe
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Martha Caterina Faraguna, Francesca Musto, Viola Crescitelli, Maria Iascone, Luigina Spaccini, Davide Tonduti, Tiziana Fedeli, Gaia Kullmann, Francesco Canonico, Alessandro Cattoni, Fabiola Dell'Acqua, Carmelo Rizzari, Serena Gasperini
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child. Genes 13 (3) (2022)
Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, Joan D Morris, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Yi Zeng, Rajendra Desai, William N Kormany, Cornelia Eckert, Anja Möricke, Mary Sartor, Ondrej Hrusak, Christina Peters, Vaskar Saha, Luciana Vinti, Arend von Stackelberg
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL. Leukemia (2022)
Luca Lo Nigro, Nellina Andriano, Barbara Buldini, Daniela Silvestri, Tiziana Villa, Franco Locatelli, Rosanna Parasole, Elena Barisone, Anna Maria Testi, Andrea Biondi, Maria Grazia Valsecchi, Carmelo Rizzari, Valentino Conter, Giuseppe Basso, Giovanni Cazzaniga
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD). Cancers 14 (10) (2022)
Giuliana Beneduce, Antonia De Matteo, Pio Stellato, Anna M Testi, Nicoletta Bertorello, Antonella Colombini, Maria C Putti, Carmelo Rizzari, Simone Cesaro, Monica Cellini, Elena Barisone, Fara Petruzziello, Giuseppe Menna, Rosanna Parasole
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers. Cancers 14 (2) (2022)
Cristina Matteo, Antonella Colombini, Laura Rachele Bettini, Luca Porcu, Silvia Barzaghi, Tommaso Ceruti, Daniela Silvestri, Angela Amoroso, Fabiola Dell'Acqua, Giacomo Gotti, Claudia Nastasi, Massimo Zucchetti, Carmelo Rizzari
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product. Pediatric blood & cancer 69 (9) (2022)
Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, Joachim Gerß, Anja Möricke, Martin Zimmermann, Jan Stary, Petr Smisek, Martin Schrappe, Carmelo Rizzari, Massimo Zucchetti, Georg Hempel, Sebastian Georg Wicha, Joachim Boos, null null
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data. European journal of drug metabolism and pharmacokinetics 46 (2) (2021)
Nobuko Hijiya, Alexey A Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco Bautista, Stéphane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frédéric Millot, Briana Patterson, Jill H Samis, Paola Aimone, Alex Allepuz, Ksenia Titorenko, Darintr Sosothikul
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood advances 5 (14) (2021)
Christian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, Petr Smisek, Christa Ellen Nath, Carmelo Rizzari, Joachim Boos, Gudrun Würthwein
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach. European journal of drug metabolism and pharmacokinetics (2021)